Company logo

ECOR - electroCore, Inc.

NASDAQ -> Healthcare -> Medical Devices
Rockaway, United States

ECOR price evolution
ECOR
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Current assets
Cash $38 $14.7 $9.06 $4.24
Short term investments $1 $9.03 $16.39 $18.39
Net receivables $0.33 $0.37 $0.26 $0.27
Inventory $5.43 $5.53 $5.62 $5.74
Total current assets $41.88 $25.41 $27.59 $25.06
Long term investments
Property, plant & equipment $0.71 $0.75 $0.72 $0.76
Goodwill & intangible assets
Total noncurrent assets $5.69 $5.89 $6.16 $6.45
Total investments $1 $9.03 $16.39 $18.39
Total assets $47.57 $31.3 $33.75 $31.52
Current liabilities
Accounts payable $1.25 $2.3 $2.11 $2.08
Deferred revenue
Short long term debt $0.06 $0.54 $1.08 $1.01
Total current liabilities $5.74 $5.76 $5.34 $5.89
Long term debt $0.72 $0.92 $1.74 $1.98
Total noncurrent liabilities $0.72 $0.92 $1.74 $1.98
Total debt $0.77 $1.47 $2.82 $2.99
Total liabilities $6.45 $6.68 $7.08 $7.87
Shareholders' equity
Retained earnings -$119.26 -$115.27 -$112.37 -$106.99
Other shareholder equity -$0.12 -$0.1 -$0.11 -$0.25
Total shareholder equity $40.48 $23.98 $26.03 $23.01
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Current assets
Cash $4.24 $13.56 $7.6 $13.22
Short term investments $18.39 $10.5 $60.96 $23.95
Net receivables $0.27 $0.5 $0.27 $0.1
Inventory $5.74 $6.91 $1.95 $0.33
Total current assets $25.06 $26.53 $72.7 $39.03
Long term investments
Property, plant & equipment $0.76 $1.78 $0.38 $0.17
Goodwill & intangible assets
Total noncurrent assets $6.45 $8.93 $0.81 $0.2
Total investments $18.39 $10.5 $60.96 $23.95
Total assets $31.52 $35.46 $73.5 $39.23
Current liabilities
Accounts payable $2.08 $5.21 $2.7 $3.88
Deferred revenue
Short long term debt $1.01 $0.6
Total current liabilities $5.89 $9.14 $7.07 $6.12
Long term debt $1.98 $1.42
Total noncurrent liabilities $1.98 $1.42 $0.25 $0.31
Total debt $2.99 $2.02
Total liabilities $7.87 $10.56 $7.32 $6.43
Shareholders' equity
Retained earnings -$106.99 -$83.48 -$38.33 -$152.93
Other shareholder equity -$0.25 -$0.04 $0.06 $0.08
Total shareholder equity $23.01 $24.26 $65.55 -$90.07
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Revenue
Total revenue $1.49 $1.27 $1.2 $0.93
Cost of revenue $0.36 $0.37 $0.36 $0.82
Gross Profit $1.13 $0.9 $0.84 $0.11
Operating activities
Research & development $0.47 $0.82 $0.5 $1.02
Selling, general & administrative $4.65 $5.27 $5.72 $5.41
Total operating expenses $5.12 $6.1 $6.22 $6.43
Operating income -$3.99 -$5.2 -$5.38 -$6.32
Income from continuing operations
EBIT -$3.98 -$3.78 -$5.38 -$6.32
Income tax expense $0.01 -$0.89
Interest expense
Net income
Net income -$3.99 -$2.89 -$5.38 -$6.32
Income (for common shares) -$3.99 -$2.89 -$5.38 -$6.32
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Revenue
Total revenue $3.5 $2.39 $0.99 $0.81
Cost of revenue $1.74 $1.16 $0.58 $0.52
Gross Profit $1.76 $1.23 $0.41 $0.29
Operating activities
Research & development $4.2 $9.9 $12.47 $7.83
Selling, general & administrative $21.84 $35.42 $42.5 $18.11
Total operating expenses $26.51 $47.32 $54.97 $25.94
Operating income -$24.75 -$46.09 -$54.55 -$25.64
Income from continuing operations
EBIT -$24.68 -$45.13 -$55.82 -$29.5
Income tax expense -$1.17 $0.02 $0
Interest expense $6.3
Net income
Net income -$23.51 -$45.15 -$55.82 -$35.79
Income (for common shares) -$23.51 -$45.15 -$55.82 -$35.79
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Net income -$3.99 -$2.89 -$5.38 -$6.32
Operating activities
Depreciation $0.1 $0.1 $0.1 $0.48
Business acquisitions & disposals
Stock-based compensation $0.76 $0.84 $0.94 $0.78
Total cash flows from operations -$3.45 -$1.67 -$4.16 -$3.09
Investing activities
Capital expenditures
Investments $8 $7.3 $1.92 $3.7
Total cash flows from investing $8 $7.3 $1.92 $3.7
Financing activities
Dividends paid
Sale and purchase of stock $18.76 $6.92 $0.35
Net borrowings -$0.49
Total cash flows from financing $18.76 $6.92 -$0.14
Effect of exchange rate -$0.02 $0.01 $0.14 -$0.06
Change in cash and equivalents $23.3 $5.63 $4.82 $0.41
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Net income -$23.51 -$45.15 -$55.82 -$35.79
Operating activities
Depreciation $0.77 $0.31 $0.07 $0.03
Business acquisitions & disposals
Stock-based compensation $3.27 $3.9 $7.6 $0.46
Total cash flows from operations -$20.1 -$45.07 -$47.11 -$25.33
Investing activities
Capital expenditures -$0.07 -$0.28 -$0.15
Investments -$7.96 $51.04 -$36.55 -$23.97
Total cash flows from investing -$7.96 $50.97 -$36.83 -$24.12
Financing activities
Dividends paid
Sale and purchase of stock $17.49 $0.05 $78.33
Net borrowings $1.46 $0.11 $19.97
Total cash flows from financing $18.95 $0.16 $78.33 $62.49
Effect of exchange rate -$0.21 -$0.1 -$0.02 -$0.23
Change in cash and equivalents -$9.32 $5.96 -$5.62 $12.81
Fundamentals
Market cap $48.22M
Enterprise value $10.99M
Shares outstanding 70.70M
Revenue $4.89M
EBITDA -$18.70M
EBIT -$19.47M
Net Income -$18.60M
Revenue Q/Q 37.59%
Revenue Y/Y 50.77%
P/E ratio -2.59
EV/Sales 2.25
EV/EBITDA -0.59
EV/EBIT -0.56
P/S ratio 9.86
P/B ratio 1.19
Book/Share 0.57
Cash/Share 0.54
EPS -$0.26
ROA -51.60%
ROE -65.53%
Debt/Equity 0.34
Net debt/EBITDA 1.69
Current ratio 7.30
Quick ratio 6.35